Actuated Medical Celebrates FDA 510(k) Clearance for their GripTract-GI™ Endoscopic Tissue Manipulator, Enhancing Complex Colonoscopy Visualization

BELLEFONTE, Pa. - Rezul -- Actuated Medical, a leading innovator in medical device technologies, proudly announces the receipt of FDA 510(k) clearance for its groundbreaking GripTract-GI™ Endoscopic Tissue Manipulator (GripTract-GI). This milestone marks a significant advancement in minimally invasive procedures, empowering healthcare professionals with a state-of-the-art tool for enhanced precision and control in complex gastrointestinal interventions.

GripTract-GI, developed and patented by Actuated Medical's team of experts, is designed to revolutionize endoscopic tissue manipulation, offering unparalleled maneuverability and versatility. With this FDA clearance, Actuated Medical reaffirms its commitment to delivering cutting-edge solutions that elevate patient care and procedural outcomes.

"The FDA clearance for GripTract-GI is a testament to Actuated Medical's dedication to innovation and excellence in medical device development," said Maureen L. Mulvihill, CEO and Founder of Actuated Medical. "This milestone underscores our commitment to advancing medical procedures, providing healthcare professionals with tools that redefine the possibilities of minimally invasive interventions."

More on Rezul News

• Harvest Properties Acquires Two San Francisco Bay Area Self Storage Facilities for $44.2 Million
• Georgia's Traditions of Braselton to Host Spring Open House Event
• ScreenPoints Puts Film Investors in the Credits—and in the Money With New FinTech Platform
• Pathways to Adulthood Conference May 17 at Melville Marriott Honoring NYS Assembly Member Jodi Giglio, Suffolk County Legislator Nick Caracappa
• Adster Techologies awarded US Patent for breakthrough innovation in reducing latency in Ad Serving

GripTract is a single-use device that connects to the distal end of an endoscope without occupying the working channel. It assists clinicians with optical visualization, diagnosis, and endoscopic treatment. It was developed under National Institutes of Health (NIH) Small Business Innovation Research (SBIR) funding.

Actuated Medical's relentless pursuit of excellence is reflected not only in the GripTract-GI but also in the company's overall portfolio, which spans various medical specialties. The FDA clearance reinforces Actuated Medical's position as a leader in medical device innovation, poised to make a lasting impact on the landscape of minimally invasive procedures.

About Actuated Medical:

Actuated Medical is a medical device product innovator with an impressive portfolio boasting six FDA 510(k) clearances, over 41 US and International patents, and three products already making waves in early sales. Their unwavering focus on neuroscience, gastrointestinal, critical care, and pediatrics is reshaping the landscape of medical technology. Operating from a cutting-edge 20,000 sq.ft. facility in central Pennsylvania, their ISO 13485 and WOSB certifications underscore their commitment to quality. Honored with two SBA Tibbets Awards for SBIR commercialization excellence and the 2020 Life Sciences PA CEO of the Year award, Actuated's remarkable journey includes a pivotal role in addressing the PPE shortage during the COVID crisis.

More on Rezul News

• Flexi-View Lending Closes $5.05 Million Residential Acquisition Loan in Billings, Montana
• Robert Fabbio Inducted into the Austin Technology Council Hall of Fame
• Data Driven Design Turns Toronto Houses into Smart Fourplexes
• Cybersecurity is Protecting Your Personal Information and Your Portfolio
• Maui Luxury Real Estate Shares May Properties for Sale!

For media inquiries, please contact: Maureen L. Mulvihill, Ph.D. by phone at 814-355-0003 or email at info@actuatedmedical.com.

Additional information can be found by visiting:

ActuatedMedical.com

ActuatedNeuroscience.com

TubeClear.com

Mitotyping.com